PMID- 28105765
OWN - NLM
STAT- MEDLINE
DCOM- 20180212
LR  - 20180212
IS  - 1879-0844 (Electronic)
IS  - 1388-9842 (Linking)
VI  - 19
IP  - 3
DP  - 2017 Mar
TI  - Phosphodiesterase-5 inhibition in heart failure with preserved ejection fraction:
      trading therapy for prevention.
PG  - 337-339
LID - 10.1002/ejhf.742 [doi]
FAU - Guazzi, Marco
AU  - Guazzi M
AD  - IRCCS Policlinico San Donato Hospital, University of Milan, Milan, Italy.
FAU - van Heerebeek, Loek
AU  - van Heerebeek L
AD  - VU University Medical Center, Amsterdam, The Netherlands.
FAU - Paulus, Walter J
AU  - Paulus WJ
AD  - VU University Medical Center, Amsterdam, The Netherlands.
LA  - eng
PT  - Editorial
PT  - Comment
DEP - 20170119
PL  - England
TA  - Eur J Heart Fail
JT  - European journal of heart failure
JID - 100887595
RN  - EC 3.1.4.35 (Cyclic Nucleotide Phosphodiesterases, Type 5)
SB  - IM
CON - Eur J Heart Fail. 2017 Mar;19(3):326-336. PMID: 27995696
MH  - Cyclic Nucleotide Phosphodiesterases, Type 5
MH  - *Heart Failure
MH  - Humans
MH  - *Stroke Volume
MH  - Ventricular Function, Left
EDAT- 2017/01/21 06:00
MHDA- 2018/02/13 06:00
CRDT- 2017/01/21 06:00
PHST- 2016/12/01 00:00 [received]
PHST- 2016/12/16 00:00 [accepted]
PHST- 2017/01/21 06:00 [pubmed]
PHST- 2018/02/13 06:00 [medline]
PHST- 2017/01/21 06:00 [entrez]
AID - 10.1002/ejhf.742 [doi]
PST - ppublish
SO  - Eur J Heart Fail. 2017 Mar;19(3):337-339. doi: 10.1002/ejhf.742. Epub 2017 Jan
      19.